Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Director, Medical Communications

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Jan 4, 2023

View more

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How You Will Achieve More with Intellia:

The Senior Director of Medical Communications will be a member of the Medical Affairs Leadership Team and will be responsible for key strategic objectives of Medical Affairs communications with external stakeholders, including the development of the Medical Information and Medical Communications Strategy. You will work closely with Medical Affairs, the Clinical Program Teams, Investor Relations & Corporate Communications, and a variety of other cross-functional teams.

Key responsibilities:

  • Lead medical communications strategy development and execution of tactical plans for all Intellia programs.

  • Responsible for the development and implementation of medical education initiatives to fill external educational gaps for a new therapeutic modality. This includes disease state awareness programs at medical congresses and broader medical education via digital and non-digital platforms via traditional and novel ways.

  • Work closely with the program teams, Scientific Communications Manager, and other internal functions to develop a long-term publication strategy for clinical programs. This includes timely publication of Intellia’s clinical trial results in peer review journals, congress presentations, disease awareness publications, and educational review articles.

  • Ensures annual development of aligned and comprehensive cross-functional medical communication plans for all Intellia Tx programs.

  • Accountable for oversight of Medical Information services, including standard response documents for all Intellia TX products, responses to all HCP and patient inquiries, and represent the Medical Affairs team in the Medical/Legal/Regulatory review process.

  • Ensure ongoing operational excellence within the Medical Communications function, including innovative solutions to the creation of documents to reactively respond to healthcare professionals and interactions with HCPs at congress booths. Drive excellence in Medical Information communication to external and internal customers across all Pharma therapeutic areas.

  • Support the brand/disease state portfolio Medical/Scientific Director(s) with planning the medical strategy and tactical plans in collaboration with other medical affairs departments, commercial, clinical development and other departments and functions, as appropriate.

  • Contribute to/deliver key Medical Communications activities including, but not limited to

    • Scientific platform: lead the development and continuous update of this foundational document for each brand/disease state portfolio entity, including core scientific statements that inform all medical communications, and a scientific lexicon for consistency. Provide education and promote awareness of the scientific platform to internal teams to drive broad use and ensure one scientific voice for the brand throughout the organization.

    • Company-sponsored symposia, advisory boards/round tables, and other medical education content support development of materials and content, in collaboration with the brand/disease state portfolio Medical Director and vendors; ensure medical accuracy and appropriate review/approval.

    • Field Medical resources: support the development of resources to meet the needs of the field medical team; ensure medical accuracy and appropriate review/approval.

  • Lead cross-functional alignment and education to ensure appropriate incorporation of scientific platform evidence statements into all medical content and medical communications for US products including, but not limited to, publications, medical information responses to unsolicited requests, slide decks, and field resources to support proactive and reactive scientific exchange.

  • Measure and report metrics on the effectiveness of medical communications content and channels

  • Ensure the scientific integrity, quality and accuracy of all deliverables with a commitment to ethical practices in the preparation and dissemination of materials.

  • Critically evaluate the published medical and scientific literature related to the Intellia tx pipeline products and relevant competitive products; maintain knowledge of product areas, current trends, and current literature.

  • Manage funds and resources appropriately, including medical communications vendors.

About You:

  • Doctoral degree (Ph.D., PharmD) in a scientific discipline with a minimum of 10 years of healthcare or related experience, inclusive of 5+ years of experience with the development and execution of medical communications deliverables, within medical affairs in the pharmaceutical or biotech industry or within a medical communications agency

  • Excellent written and oral communication skills

  • Strong organizational leadership and experience working in a matrix environment

  • Vendor management experience

  • Demonstrated results in one or more medical communications groups (e.g., medical communications, publications, medical information, training).

  • Understanding of pharmaceutical clinical development and product life-cycle management

  • Cross-functional team participation within the Pharmaceutical or related industry

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert